We are live on ! Find out more
CCM

Cutter Capital Management Portfolio holdings

AUM $230M
1-Year Est. Return 11.53%
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
+11.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
-$14.4M
Cap. Flow
-$13.6M
Cap. Flow %
-5.94%
Top 10 Hldgs %
62.84%
Holding
31
New
10
Increased
5
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$17.2M
2
BIIB icon
Biogen
BIIB
+$16.2M
3
LLY icon
Eli Lilly
LLY
+$15M
4
ROIV icon
Roivant Sciences
ROIV
+$14.1M
5
VRNA
Verona Pharma
VRNA
+$9.57M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$22.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$20.5M
3
ABBV icon
AbbVie
ABBV
+$18.1M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$15.1M
5
RPRX icon
Royalty Pharma
RPRX
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNA icon
26
Moderna
MRNA
$23.6B
– –
-197,500
Closed -$8.21M
NMRA icon
27
Neumora Therapeutics
NMRA
$302M
– –
-150,000
Closed -$1.59M
REGN icon
28
Regeneron Pharmaceuticals
REGN
$70.5B
– –
-31,500
Closed -$22.4M
SRPT icon
29
Sarepta Therapeutics
SRPT
$1.78B
– –
-124,256
Closed -$15.1M
VERA icon
30
Vera Therapeutics
VERA
$2.66B
– –
-212,696
Closed -$8.99M
VRDN icon
31
Viridian Therapeutics
VRDN
$2.05B
– –
-628,677
Closed -$12.1M
1
2

Similar funds

SAM
Selway Asset Management $242M AUM 7.7% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
IAM
Impact Asset Management Vienna $255M AUM
BCM
BluePointe Capital Management Menlo Park, California $262M AUM 9.24% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return
LA
Lane & Associates Moorestown, New Jersey $186M AUM 5.34% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

Cutter Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Cutter Capital Management held 31 positions worth $230M, down 5.9% from $244M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Cutter Capital Management withdrew a net $13.6M in Q1 2025, closing 10 positions and reducing 6 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $22.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Cutter Capital Management opened a new position in Bristol-Myers Squibb worth $18M.

  • Cutter Capital Management's largest Q1 2025 buy was Bristol-Myers Squibb: 295,000 shares worth $18M.
  • Cutter Capital Management added most to Perrigo in Q1 2025, an estimated $4.8M increase.
  • Cutter Capital Management's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $12.9M.
  • Cutter Capital Management fully exited Regeneron Pharmaceuticals in Q1 2025, selling an estimated $22.4M.
  • Cutter Capital Management's ten largest holdings make up 63% of its $230M portfolio in Q1 2025.
  • Cutter Capital Management opened 10 new positions and closed 10 in Q1 2025.
  • Cutter Capital Management's portfolio value fell 5.9% quarter-over-quarter to $230M.

Based on Cutter Capital Management's 13F filing for Q1 2025, filed 15 May 2025.